Fisher & Paykel (ASX: FPH) Updates Profit Forecast for FY25

2 min read | August 23, 2024 10:34 AM AEST | By Team Kalkine Media

Fisher & Paykel Healthcare Corporation Ltd (ASX:FPH) has revised its profit forecast for the fiscal year 2025, anticipating a net profit after tax (NPAT) of between $320 million and $370 million. This forecast represents an increase from the previously indicated range of $310 million to $360 million provided in May.

The adjustment is attributed to the company's introduction of new products and ongoing changes in clinical practices. Fisher & Paykel, which specializes in acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment, maintains its operating revenue guidance at approximately $1.9 billion to $2.0 billion.

CEO Lewis Gradon highlighted that the forecasted profit growth is supported by strong performance across all product lines and regions. The company has observed a positive response to new product launches and a high hospital census, with Northern Hemisphere seasonal hospitalizations extending into the start of the financial year. Additionally, Fisher & Paykel has noted progress in its gross margin improvement initiatives.

For the first half of FY2025, ending September 30, 2024, Fisher & Paykel projects revenue between $940 million and $950 million, with an NPAT ranging from $150 million to $160 million. This forecast reflects an approximate 18% increase in operating revenue and a 44% increase in NPAT compared to the first half of the 2024 fiscal year.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.